The importance of getting the right value creation across the product life cycle at the right time has never been greater in biopharma now the costs of developing, launching and commercialisation of drugs are growing. Especially when new therapies target smaller patient populations and competition and payer influence continues to increase.

As a collaborator, facilitator, and co-creator Launch & Lifecycle supports biopharma and medical devices companies to ensure sustainable access for medicines, medical devices and/or combinations. We partner to diagnose the value creation opportunities, design impactful value based solutions, and deliver results.